BIOLOGICS, INC.

Biologics, Inc. specializes in the manufacturing and supply of critical pharmaceutical preparations, with deep expertise in oncology biologics and targeted cancer therapeutics. The company delivers FDA-regulated drug products, including branded and generic formulations such as lenalidomide and turalio, under strict cGMP standards. Their technical capabilities encompass active pharmaceutical ingredient (API) processing, lyophilization, sterile fill-finish operations, and NDC-compliant packaging for federal distribution channels. A key differentiator is their consistent ability to fulfill time-sensitive, high-integrity orders for complex biologic agents, demonstrating reliability in the supply chain for life-saving therapies. The contractor maintains a strong, recurring relationship with the Department of Justice, consistently supplying cancer biologics through McKesson’s federal distribution network, indicating a trusted role in procuring specialty pharmaceuticals for correctional and law enforcement health systems. They also support the Department of Veterans Affairs with direct pharmaceutical deliveries, suggesting alignment with VA’s specialty pharmacy and formulary management protocols. These engagements reflect a pattern of sole-source and direct procurement relationships rooted in regulatory compliance and supply chain continuity. Biologics, Inc. operates exclusively within NAICS 325412—Pharmaceutical Preparation Manufacturing—positioning itself as a niche supplier of specialty oncology biologics to government health and justice systems. Their market focus is narrow but mission-critical, serving federal agencies that require secure, compliant access to high-cost, low-volume therapeutics. This vertical specialization distinguishes them from broad-spectrum pharmaceutical distributors. As a small business structured as a 2L entity based in Cary, North Carolina, Biologics, Inc. maintains a focused operational footprint with no public certifications listed. Their government market positioning is defined by technical precision in biologic manufacturing and consistent performance in high-stakes, regulated procurement environments.